InStride Health
InStride Health provides insurance-based, specialty outpatient care for pediatric anxiety and OCD across several northeastern states, utilizing a multidisciplinary team and various therapy options.
Services
InStride Health provides insurance-based, specialty outpatient care for pediatric anxiety and OCD. Their services include individual, family, and group therapy, caregiver therapy, and medication management. They utilize a multidisciplinary care team that features a psychiatrist, therapist, and exposure coach. Treatment is conducted using everyday tools such as text, chat, and video to support kids, teens, and young adults in real-world settings. They also offer booster sessions for additional support post-treatment and a parent-only treatment track for situations where the child is unwilling or unable to participate in therapy.
Regional Availability
InStride Health's services are available in Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, and Rhode Island. The wide geographic spread ensures that families across multiple states can access their specialized outpatient care for pediatric anxiety and OCD.
Insurance Plans Accepted
InStride Health accepts most major commercial insurance plans to eliminate barriers to accessing their services. Insurance plans accepted include Anthem BCBS, Blue Cross Blue Shield, ConnectiCare, EmblemHealth, Harvard Pilgrim, Horizon Blue Cross Blue Shield, Mass General Brigham Health Plan, NYSHIP, Optum, Oscar, Oxford, UnitedHealthcare, and Wellpoint.
Collaborations and Partnerships
InStride Health collaborates with several organizations to enhance treatment and accessibility. These include McLean Hospital, Violet, and Hopelab. They also work closely with pediatricians and schools to provide support and training for parents, caregivers, and families, ensuring a comprehensive support system for their patients.
Annual Outcomes Report
InStride Health released its first annual outcomes report in October 2023. The report demonstrates clinically meaningful results from treating over 350 patients. This documentation serves as a testament to the efficacy of their treatment programs and their commitment to evidence-based care.